Location: Home
  • search
  • go
  • Relate News
  • 12/30/2024Duality Announces B7H4 ADC Milestone and License Exercise by BeiGene
  • 12/30/2024CARsgen Reports Positive Topline Results from China GC/GEJ Pivotal Pha...
  • 12/30/2024Reforgene Secures Major Financing to Advance Gene-Editing Therapies
  • 12/30/2024TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...
  • 12/30/20242025 Forecast: What Can AstraZeneca's China Probes Teach Other Biophar...
  • 12/29/2024IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for AD...
  • 12/29/2024Hong Kong Accepts IPO Application from GenFleet Therapeutics
  • 12/29/2024CSRC Approves Ascentage Pharma's U.S. IPO Filing
  • 12/27/2024Review of China's Hospital Drug Market: Strong Competition Amid Slight...
  • 12/27/2024China's Innovative Drug Approvals in 2024 and Blockbusters Anticipated...
  • 12/27/2024China's Commercial Health Insurance: Growth Trends and Challenges in C...
  • 12/27/2024Collaborative Governance Mechanism for Healthcare, Medical Insurance, ...
  • 12/27/2024CDE Issues the List of Reference Formulations for GQCE Studies (87th B...
  • 12/27/2024AusperBio Secures $73M in Series B Financing to Advance Functional Cur...
  • 12/27/2024Recent Executive Moves
  • 12/26/2024Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
  • 12/25/2024NMPA Announces Package Insert Revision of Human Tetanus Immunoglobulin...
  • 12/25/2024China NMPA Accepts NDA for ARS Pharma's Epinephrine Nasal Spray
  • 12/25/2024Auzone Submits NDA for TTYP01 to FDA, Anticipates 2025 Approval
  • 12/25/2024Eli Radiopharma Raises Funds to Accelerate Radiopharma Innovations
  • 12/25/2024Hechuang Biotech Secures Series A Funding to Advance CGT Research
  • 12/25/2024Huaota Biopharma Secures CNY 200M in Financing to Drive R&D
  • 12/24/2024CDE Seeks Comments on the Supplementary List of External Experts for t...
  • 12/24/2024 Ascentage Pharma Secures Chinese Regulatory Approval for U.S. Nasdaq ...
  • 12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
  • 12/24/2024State Council Moves to Advance Pharma Reforms and Regulatory Streamlin...
  • 12/24/2024WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
  • 12/24/2024Fosun Pharma's Parent Company Pledges 27% of Its A-shares
  • 12/24/2024Sanofi Reaffirms Commitment to China's Growing Biopharmaceutical Secto...
  • 12/23/2024Shionogi Acquires Pingan's Stake in AI-Focused JVs
  • Page:47/790 Total number of articles:23674: [First][<<] [45] [46] [47] [48] [49] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group